|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Operating expenses | ||||
| Net impairment losses on financial assets | ||||
| Operating profit | ||||
| Finance income | ||||
| Finance cost | ||||
| Share of profit from associates net of tax | ||||
| Profit before income tax | ||||
| Income tax expense | ||||
| Profit from continuing operations | ||||
| Profit from discontinued operations | ||||
| Profit for the year | ||||
| Profit for the year attributable to: | ||||
| Equity holders of the Company | ||||
| Other comprehensive income: | ||||
| Items that are not reclassified subsequently to the income statement: | ||||
| Remeasurement of net defined benefit liability | ||||
| Net exchange adjustments offset in reserves | ||||
| Net (loss)/gain on net investment hedge | ||||
| Items that are or may be reclassified subsequently to the income statement: | ||||
| Net exchange adjustments offset in reserves | ||||
| Net gain/(loss) on net investment hedge | ||||
| Effective portion of changes in fair value of cash flow hedge | ||||
| Cost of hedging | ||||
| Tax related to items taken to other comprehensive income | ||||
| Net exchange adjustments transferred to profit on disposal of business | ||||
| Net gain on net investment hedge transferred to profit on disposal of business | ||||
| Other comprehensive income for the year | ||||
| Total comprehensive income for the year | ||||
| Total comprehensive income for the year attributable to: | ||||
| Equity holders of the Company | ||||
| Earnings per share attributable to the Company's equity holders: | ||||
| Basic from continuing operations | ||||
| Diluted from continuing operations | ||||
| Basic from continuing and discontinued operations | ||||
| Diluted from continuing and discontinued operations |
Loading...